Hydroxychloroquinesulfaat Cf

Hydroxychloroquine, the active ingredient in Hydroxychloroquinesulfaat Cf, is an antimalarial drug presented as a tablet for oral use. It is used to treat malaria, rheumatoid arthritis and systemic lupus erythematosus in adults.

GNH USA supplies Hydroxychloroquinesulfaat Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxychloroquine is employed in the management of parasitic infections and autoimmune diseases.

- Malaria: effective in treating acute uncomplicated malaria caused by susceptible Plasmodium species. - Rheumatoid arthritis: reduces disease activity and joint inflammation in adult patients. - Systemic lupus erythematosus: helps control disease flares and skin manifestations in adults.

Hydroxychloroquine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: occasional upset stomach. - Headache: mild to moderate intensity. - Abdominal pain: intermittent discomfort. - Diarrhea: loose stools. - Rash: skin redness or itching. - Pruritus: generalized itching.

Serious or Rare Side Effects: - Retinopathy: progressive vision loss requiring ophthalmologic monitoring. - Cardiomyopathy: heart muscle dysfunction, potentially leading to heart failure. - Severe hypoglycemia: especially in diabetic patients on insulin or sulfonylureas. - Blood dyscrasias: including anemia, leukopenia, or thrombocytopenia. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Neuropsychiatric effects: including mood changes or seizures.

Before initiating therapy, several safety considerations should be addressed.

- Pregnancy: safety not established; use only if potential benefit justifies the risk. - Retinal monitoring: baseline eye examination and periodic follow‑up are recommended. - Cardiac assessment: evaluate ECG in patients with known cardiac disease or risk factors. - Blood glucose: monitor diabetic patients closely for hypoglycemia. - Drug interactions: review all concomitant medications for potential interactions. - Store at room temperature: keep in the original container, protect from moisture and light.

Hydroxychloroquine can interact with several medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Azithromycin: combined use may increase QT‑prolongation risk. - Other QT‑prolonging agents: avoid co‑administration to prevent cardiac arrhythmias. - Strong CYP450 inhibitors (e.g., ketoconazole): may raise hydroxychloroquine plasma levels. - Insulin or oral hypoglycemics: may cause severe hypoglycemia. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect.

Moderate Interactions (Monitor Closely): - Rifampicin: may reduce hydroxychloroquine exposure, decreasing efficacy. - Enzyme‑inducing antiepileptics (e.g., carbamazepine): may lower drug concentrations. - Live vaccines: hydroxychloroquine may diminish vaccine efficacy.